☆ 4.7 Letter

SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Related references

Note: Only part of the references are listed.
Letter Immunology

Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021

Haogao Gu et al.

Summary: Despite strict quarantine precautions, transmission of the Omicron variant occurred between fully vaccinated travelers in a quarantine hotel in Hong Kong, China.

EMERGING INFECTIOUS DISEASES (2022)

Add to Collection
Letter Immunology

Significantly reduced abilities to cross-neutralize SARS-CoV-2 variants by sera from convalescent COVID-19 patients infected by Delta or early strains

Ting Pan et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Add to Collection
Review Microbiology

SARS-CoV-2 variants, spike mutations and immune escape

William T. Harvey et al.

Summary: The evolution of SARS-CoV-2 has been characterized by the emergence of mutations and variants that impact virus characteristics. Manufacturers are preparing for possible updates to vaccines in response to changes in the virus population, and it is crucial to monitor genetic and antigenic changes alongside experiments to understand the impacts of mutations.

NATURE REVIEWS MICROBIOLOGY (2021)

Add to Collection
Article Medicine, Research & Experimental

SARS-CoV-2 Omicron variant: Characteristics and prevention

Xuemei He et al.

Summary: The new SARS-CoV-2 variant B.1.1.529 named Omicron, reported in South Africa, has raised global concerns after being designated as a variant of concern by the WHO. With a high number of mutations, including 15 in the spike receptor-binding domain, the Omicron variant shares similarities with previous VOCs, sparking worries about its transmissibility and immune evasion.

MEDCOMM (2021)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.